These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 30946543)

  • 1. Oral Ketamine for Depression, 1: Pharmacologic Considerations and Clinical Evidence.
    Andrade C
    J Clin Psychiatry; 2019 Apr; 80(2):. PubMed ID: 30946543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral Ketamine for Depression, 2: Practical Considerations.
    Andrade C
    J Clin Psychiatry; 2019 Apr; 80(2):. PubMed ID: 30997961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketamine for Depression, 4: In What Dose, at What Rate, by What Route, for How Long, and at What Frequency?
    Andrade C
    J Clin Psychiatry; 2017 Jul; 78(7):e852-e857. PubMed ID: 28749092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral ketamine for the treatment of pain and treatment-resistant depression†.
    Schoevers RA; Chaves TV; Balukova SM; aan het Rot M; Kortekaas R
    Br J Psychiatry; 2016 Feb; 208(2):108-13. PubMed ID: 26834167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral Ketamine for Depression: A Systematic Review.
    Rosenblat JD; Carvalho AF; Li M; Lee Y; Subramanieapillai M; McIntyre RS
    J Clin Psychiatry; 2019 Apr; 80(3):. PubMed ID: 30995364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ketamine for depression clinical issues.
    Iqbal SZ; Mathew SJ
    Adv Pharmacol; 2020; 89():131-162. PubMed ID: 32616205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is ketamine effective and safe for treatment-resistant depression?
    Zorn A; Linn S; Jenkinson M; Neher JO; Safranek S; Kelsberg G
    J Fam Pract; 2021 Apr; 70(3):E1-E3. PubMed ID: 34314342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness and Safety of Ketamine for Unipolar Depression: a Systematic Review.
    Memon RI; Naveed S; Faquih AE; Fida A; Abbas N; Chaudhary AMD; Qayyum Z
    Psychiatr Q; 2020 Dec; 91(4):1147-1192. PubMed ID: 32852658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Placebo-controlled pilot trial testing dose titration and intravenous, intramuscular and subcutaneous routes for ketamine in depression.
    Loo CK; Gálvez V; O'Keefe E; Mitchell PB; Hadzi-Pavlovic D; Leyden J; Harper S; Somogyi AA; Lai R; Weickert CS; Glue P
    Acta Psychiatr Scand; 2016 Jul; 134(1):48-56. PubMed ID: 27028832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ketamine as a new treatment for depression: a review of its efficacy and adverse effects.
    Katalinic N; Lai R; Somogyi A; Mitchell PB; Glue P; Loo CK
    Aust N Z J Psychiatry; 2013 Aug; 47(8):710-27. PubMed ID: 23661785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Daily oral ketamine for the treatment of depression and anxiety in patients receiving hospice care: a 28-day open-label proof-of-concept trial.
    Irwin SA; Iglewicz A; Nelesen RA; Lo JY; Carr CH; Romero SD; Lloyd LS
    J Palliat Med; 2013 Aug; 16(8):958-65. PubMed ID: 23805864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid antidepressant effect of S-ketamine in schizophrenia.
    Bartova L; Papageorgiou K; Milenkovic I; Dold M; Weidenauer A; Willeit M; Winkler D; Kasper S
    Eur Neuropsychopharmacol; 2018 Aug; 28(8):980-982. PubMed ID: 30041987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeat-dose ketamine augmentation for treatment-resistant depression with chronic suicidal ideation: A randomized, double blind, placebo controlled trial.
    Ionescu DF; Bentley KH; Eikermann M; Taylor N; Akeju O; Swee MB; Pavone KJ; Petrie SR; Dording C; Mischoulon D; Alpert JE; Brown EN; Baer L; Nock MK; Fava M; Cusin C
    J Affect Disord; 2019 Jan; 243():516-524. PubMed ID: 30286416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single Subcutaneous Ketamine Dose Followed by Oral Ketamine for Depression Symptoms in Hospice Patients: A Case Series.
    Latuga NM; Luczkiewicz DL; Grant PC; Levy K; Hansen E; Kerr CW
    J Pain Palliat Care Pharmacother; 2021 Jun; 35(2):106-112. PubMed ID: 33847212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of oral ketamine augmentation on hospital admissions in treatment-resistant depression and PTSD: a retrospective study.
    Hartberg J; Garrett-Walcott S; De Gioannis A
    Psychopharmacology (Berl); 2018 Feb; 235(2):393-398. PubMed ID: 29151192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maintenance ketamine treatment for depression: a systematic review of efficacy, safety, and tolerability.
    Smith-Apeldoorn SY; Veraart JK; Spijker J; Kamphuis J; Schoevers RA
    Lancet Psychiatry; 2022 Nov; 9(11):907-921. PubMed ID: 36244360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study.
    Hu YD; Xiang YT; Fang JX; Zu S; Sha S; Shi H; Ungvari GS; Correll CU; Chiu HF; Xue Y; Tian TF; Wu AS; Ma X; Wang G
    Psychol Med; 2016 Feb; 46(3):623-35. PubMed ID: 26478208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Safety of a Rapid Intravenous Injection of Ketamine 0.5 mg/kg in Treatment-Resistant Major Depression: An Open 4-Week Longitudinal Study.
    Vidal S; Gex-Fabry M; Bancila V; Michalopoulos G; Warrot D; Jermann F; Dayer A; Sterpenich V; Schwartz S; Vutskits L; Khan N; Aubry JM; Kosel M
    J Clin Psychopharmacol; 2018 Dec; 38(6):590-597. PubMed ID: 30346333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of oral ketamine versus diclofenac to alleviate mild to moderate depression in chronic pain patients: A double-blind, randomized, controlled trial.
    Jafarinia M; Afarideh M; Tafakhori A; Arbabi M; Ghajar A; Noorbala AA; Saravi MA; Agah E; Akhondzadeh S
    J Affect Disord; 2016 Nov; 204():1-8. PubMed ID: 27317968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is off-label repeat prescription of ketamine as a rapid antidepressant safe? Controversies, ethical concerns, and legal implications.
    Zhang MW; Harris KM; Ho RC
    BMC Med Ethics; 2016 Jan; 17():4. PubMed ID: 26768892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.